PGEN - PRECIGEN INC
This page shows which of the focused investors we track hold PGEN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2022 it was held by 5 managers with an aggregate reported value of $42.25M, which is 0.00% of the combined portfolio.
As of Q1 2022, 5 tracked institutional managers held PGEN (PRECIGEN INC) with an aggregate reported value of $42.25M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades PGEN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2022
- Ticker
- PGEN
13F data is delayed and excludes shorts/non-13F assets.
Long holders
| 1 | Bill Miller - Miller Value Partners | 0.51% | Reduce -0.7% | 6,391,355 | $13.49M |
| 2 | Samantha McLemore - Patient Capital Management | 0.25% | - | 298,200 | $629K |
Call holders — bullish via leverage
1 manager holds call options on PGEN — a right to buy at strike. Notional value, not premium.
| 1 | Samantha McLemore - Patient Capital Management | New | 450,000 | $950K |
Other instruments
Bonds, warrants, or other non-share-class principal positions in PGEN.
| 1 | Howard Marks - Oaktree Capital Management | Add +10.2% | 32,429,000 | $26.4M |
| 2 | Samantha McLemore - Patient Capital Management | New | 1,000,000 | $786K |